[1]
Yang HS, Goudsouzian N, Martyn JA. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro. Anesthesiology. 1996 Apr:84(4):936-44
[PubMed PMID: 8638849]
[2]
Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Current neuropharmacology. 2013 May:11(3):315-35. doi: 10.2174/1570159X11311030006. Epub
[PubMed PMID: 24179466]
[3]
Tunsaringkarn T, Zapuang K, Rungsiyothin A. The Correlative Study of Serum Pseudo-cholinesterase, Biological Parameters and Symptoms Among Occupational Workers. Indian journal of clinical biochemistry : IJCB. 2013 Oct:28(4):396-402. doi: 10.1007/s12291-013-0322-3. Epub 2013 Apr 3
[PubMed PMID: 24426243]
[4]
Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nature reviews. Neuroscience. 2003 Feb:4(2):131-8
[PubMed PMID: 12563284]
[5]
Mack A,Robitzki A, The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study. Progress in neurobiology. 2000 Apr;
[PubMed PMID: 10739090]
[6]
Kuhnert BR, Philipson EH, Pimental R, Kuhnert PM. A prolonged chloroprocaine epidural block in a postpartum patient with abnormal pseudocholinesterase. Anesthesiology. 1982 Jun:56(6):477-8
[PubMed PMID: 7081736]
[7]
Williams J, Rosenquist P, Arias L, McCall WV. Pseudocholinesterase deficiency and electroconvulsive therapy. The journal of ECT. 2007 Sep:23(3):198-200
[PubMed PMID: 17805000]
[8]
Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. Journal of neurochemistry. 1986 Jul:47(1):263-77
[PubMed PMID: 3711902]
[9]
Lee S,Han JW,Kim ES, Butyrylcholinesterase deficiency identified by preoperative patient interview. Korean journal of anesthesiology. 2013 Dec;
[PubMed PMID: 24478828]
Level 3 (low-level) evidence
[10]
Soliday FK, Conley YP, Henker R. Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired, and drug influences. AANA journal. 2010 Aug:78(4):313-20
[PubMed PMID: 20879632]
[11]
Jasiecki J, Żuk M, Krawczyńska N, Jońca J, Szczoczarz A, Lewandowski K, Waleron K, Wasąg B. Haplotypes of butyrylcholinesterase K-variant and their influence on the enzyme activity. Chemico-biological interactions. 2019 Jul 1:307():154-157. doi: 10.1016/j.cbi.2019.05.007. Epub 2019 May 6
[PubMed PMID: 31071335]
[12]
Gabriel AJ, Almeida MR, Ribeiro MH, Carneiro D, Valério D, Pinheiro AC, Pascoal R, Santana I, Baldeiras I. Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease. Journal of Alzheimer's disease : JAD. 2018:61(3):1097-1105. doi: 10.3233/JAD-170695. Epub
[PubMed PMID: 29254094]
[13]
Munir S,Habib R,Awan S,Bibi N,Tanveer A,Batool S,Nurulain SM, Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder. Journal of molecular neuroscience : MN. 2019 Mar;
[PubMed PMID: 30707402]
[14]
Ramachandran J, Sajith KG, Priya S, Dutta AK, Balasubramanian KA. Serum cholinesterase is an excellent biomarker of liver cirrhosis. Tropical gastroenterology : official journal of the Digestive Diseases Foundation. 2014 Jan-Mar:35(1):15-20
[PubMed PMID: 25276901]
[15]
Zarday Z, Deery A, Tellis I, Soberman R, Foldes FF. Plasma and red cell cholinesterase activity in uremic patterns (effects of hemodialysis and renal transplantation). Journal of medicine. 1975:6(5-6):337-49
[PubMed PMID: 768397]